2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Treatment Considerations, Combination Therapy, Therapy Sequence, Biological Therapies, Transplantation, (CAR)-T Cell Therapies, Non-Biological Therapies, Chemotherapy, Adverse Events, Biological Processes, Immune Mechanism, Clinical Practice (Health Services and Quality), Patient Safety, Diseases, Bone Marrow Failure Syndromes, Lymphoid Malignancies, Lymphoid Leukemias, Lymphomas, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, ALL, Non-Hodgkin Lymphoma, B Cell Lymphoma, T Cell Lymphoma, Research, AML, MDS, MPN, Clinical Research, Clinical Trials, Health Outcomes Research, Health Disparities Research, Real-World Evidence, Registries, Study Population, Human, Adult, Pediatric, Young Adult
PAPER

4294 Adverse social drivers of health are associated with an elevated pre-transplant inflammatory cytokine profile and intensive care admission following pediatric hematopoietic cell transplantation

Gaelen Dwyer, MD, PhD, Elyssa Feuer2, Gregory Yanik, MD3, Sung Choi, MD4
1 University of Michigan, Ann Arbor, Michigan, United States
2 University of Toledo Medical School, Toledo, Ohio, United States
3 University of Michigan, Ann Arbor, Michigan, United States
4 University of Michigan, Ann Arbor, Michigan, United States

Background: Following long-term outcomes and adverse events after allogeneic hematopoietic cell transplantation (HCT) allows identification of high-risk patients and development of intervention strategies. Social drivers of health (SDOH), captured in part through neighborhood-level social vulnerability, are increasingly recognized as contributors to morbidity and mortality after HCT. Prior work showed increased expression of pro-inflammatory genes in pre-AlloHCT patients of low socioeconomic status, but whether these findings translate to the circulating cytokine milieu before HCT remains unclear. We hypothesized that higher neighborhood social vulnerability would be associated with an elevated pre-HCT inflammatory cytokine profile and with early post-HCT critical illness.

Methods: We performed a retrospective review of HCT recipients at the University of Michigan from 2013–2023 (IRB HUM00043287). Data were extracted using DataDirect and EMERSE. Patient addresses at transplant were mapped to census tract and linked to CDC Social Vulnerability Index (SVI) theme percentiles; socioeconomic status, household characteristics, racial/ethnic status and language, and housing type/transportation. SVI was analyzed continuously and by quartile; for cytokine comparisons, higher vulnerability was defined as SVI>0.50. Among consented patients with banked plasma, 21 pre-HCT analytes were measured using one value per transplant, selected nearest to day 0. Associations were tested using Wilcoxon rank-sum and Spearman correlation analyses, with batch-stratified testing for confirmation. Benjamini-Hochberg FDR correction was applied.

Results: Among 412 HCTs, 246 were allogeneic and 166 were autologous. Higher vulnerability in the housing type/transportation domain was associated with ICU admission within 180 days after HCT (P=0.019), while other SVI domains showed directionally similar trends. Medicaid insurance was associated with a nonsignificant trend toward higher ICU admission, 64% vs 53%, (P=0.11). ICU admission within 180 days was associated with death within nine years (P<0.01). Median ICU length of stay increased across housing type/transportation SVI quartiles, from 3.0 days in Q1 to 5.5 days in Q4.

Pre-transplant plasma was available for 119 recipients, of whom 27 were subsequently admitted to the ICU. Patients with higher vulnerability had higher pre-HCT inflammatory cytokine levels across multiple SVI domains. The strongest association was observed for CCL-4, which was increased with higher racial/ethnic minority status (P=0.001); other associations included higher IL-8 with socioeconomic vulnerability (P=0.004) and housing type/transportation vulnerability (P=0.028); higher HGF with socioeconomic (P=0.022) and household vulnerability (P=0.031), and higher IL-6 with housing and transportation vulnerability (P=0.043).

Several analytes associated with higher SVI were also elevated at baseline among patients who later required ICU admission, although these comparisons were underpowered. Compared with patients not admitted to the ICU, those subsequently admitted had higher pre-HCT IL-8 (1.67-fold, AUC 0.60, 95% CI 0.47–0.72), IL-5 (2.27-fold), IL-6 (2.05-fold), and ST2 (1.26-fold). These differences did not remain significant after correction for multiple comparisons, with lowest P=0.13, and the analysis was powered only to detect AUC ≥0.68.

Conclusion: Higher neighborhood-level social vulnerability, particularly in the housing type/transportation domain, was associated with ICU admission and longer ICU stays after HCT. Patients from more socially vulnerable neighborhoods also entered transplant with a more inflammatory cytokine profile, extending prior transcriptional observations to plasma protein markers. These findings suggest that baseline inflammation may represent a pathway linking SDOH to early critical illness after HCT. Larger studies with multivariable adjustment and analyses stratified by transplant type are needed to validate these associations.

Gaelen Dwyer, MD, PhD: No relevant conflicts of interest to declare.